Electronic Sequence Listing in Application (EFS)

Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0651-0024 can be found here:

Documents and Forms

Document Name Document Type
biosequence-screens.doc Screenshots from ePAVE software for filing sequence listings electronically via EFS IC Document

Information Collection (IC) Details

IC Title:	Electronic Sequence Listing in Application (EFS)	Agency IC Tracking Number:

Is this a Common Form? No		IC Status: New

Obligation to Respond: Required to Obtain or Retain Benefits

CFR Citation: 37 CFR 1.821-1.825

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability

Line of Business: Economic Development

Subfunction: Intellectual Property Protection

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 2,270	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits, Not-for-profit institutions

Percentage of Respondents Reporting Electronically: 100 %

	Approved	Change Due to Adjustment in Agency Estimate
Annual Number of Responses for this IC	2,270	2,270
Annual IC Time Burden (Hours)	386	386
Annual IC Cost Burden (Dollars)	180	180

Documents for IC

Title	Document	Date Uploaded
Screenshots from ePAVE software for filing sequence listings electronically via EFS	biosequence-screens.doc	09/13/2006

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.